Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:19
Asia Markets Under Pressure After Treasuries Slide: Markets Wrap
Shares in Asia fell after Jerome Powell warned interest rates may have to climb further, stunting a rally
2023-11-10 10:17
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:47
China Looks to Attract Foreign Investment as Its Economy Struggles
China’s latest attempt to reverse the nation’s foreign investment slump includes pledges to offer overseas firms better tax
2023-08-14 15:22
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 15:27
European Stocks Muted After First-Half Gains; Energy Shares Rise
European stocks were muted on Monday following gains in the first half of the year as cyclical sectors
2023-07-03 21:20
AstraZeneca Drops on Concern Over Results From Lung Cancer Drug
AstraZeneca Plc shares fell as results from a high-level study of a new cancer medicine raised concern the
2023-07-03 15:24
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:28
Novartis Makes $3.5 Billion Bet on Chinook’s Rare Disease Drugs
Novartis AG agreed to buy Chinook Therapeutics Inc. for as much as $3.5 billion to add two promising
2023-06-12 15:59
Britain’s Post-Brexit Policy Drift Alarms World’s Executives
When Dan Vahdat set out to build a healthcare startup, the UK was an ideal launchpad. That was
2023-06-12 07:29
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:15
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20